Transdermal drug delivery system: a comprehensive review
Abstract
In current scenario about 74% drugs are taken orally and are found not to be as desired. Transdermal drug distribution system used to make such characters more efficient. Drug distribution through the skin is known as normally transdermal to check the systemic effect of the drug. Drug distribution and traditional magazine is different from drug distribution. TDDS is in the from of hoofs. Adhesive of transdermal drug distribution system are important for safety , efficacy, and product quality. Occasional praise of the therapeutic agent gives a lot of benefits and drug distribution over traditional oral and intramuscular drugs. Many of the important benefits of transdermal drug distribution are the extent of metabolism near the liver. Increased in bioavailability of stable plasma fixation of drug. provides or overview of article types Transdermal patch preparation and physicochemical methods are evaluate.
Keywords:
TDDS, Topical drug delivery, Systemic blood circulation
Downloads
Download data is not yet available.
References
1. Jain NK Advances in controlled and novel drug delivery, 1st Ed., CBS Publishers and Distributers, New Delhi, 2001 pp.108-110.
2. Chioma ED. Formulation and evaluation of etodolac niosomes by modified ether injection technique. Universal Journal of Pharmaceutical Research 2016; 1(1): 1-4.
3. Chein Y.W.Transdermal drug delivery and delivery system. In, Novel drug delivery system, Vol. 50, Marcel Dekker, Inc., New York, 1992 pp.301-381.
4. Nwobodo NN, Adamude FA, Dingwoke EJ, Ubhenin A. Formulation and evaluation of elastic liposomes of decitabine prepared by rotary evaporation method. Universal Journal of Pharmaceutical Research 2019; 4(3):1-5.
5. Baker W. And Heller J, “Material selection for transdermal delivery system”. In Transdermal drug delivery development issues and research initiatives’, J. Had graft and R.H. guys, Eds, Marcel Dekker, Inc., New York 1989 pp. 293-311.
6. Gurpınar SS, Devrim B, Eryılmaz M. In-vitro antibacterial activity of lactobacilli metabolites loaded hydrogel formulations against pseudomonas aeruginosa. Universal Journal of Pharm Research 2019; 4(4): 9-11.
7. Yamamoto T, Katakabe k, Akiyoshi k, Kank and Asano T. Topical application of glibenclamide lowers blood glucose levels in rats. Diabetes res. clin. PR act 1990:8:19-22.
8. AI-Khamis K. Davis S.S and Had Graft J. Microviscosity and drug release from topical gel formulations Pharm Res.1986; 3: 214-217.
9. Fatima AA, Chukwuka UK. Development and in-vitro evaluation of matrix-type transdermal patches of losartan potassium. Universal Journal of Pharmaceutical Research 2017; 2(2): 16-20.
10. Anon. Transdermal Delivery Systems general drug release standards Pharmacopeia form 1980:14:3860-3865.
11. Brahmankar D.M. Jaiswal.S.B, Biopharmaceutics and Pharmacokinetics A Teatise. Vallabh Prakashan, Delhi 1995, 335-371.
12. Ugochukwu AE, Nnedimkpa OJ, Rita NO. Preparation and characterization of Tolterodine tartrate proniosomes, Universal Journal of Pharmaceutical Research 2017; 2(2): 1-3.
13. Ansel.H.C, Loyd.A.V, Popovich. N.G, Pharmaceutical dosage forms and drug delivery systems. Seventh edition Lippincott Williams and Willkins publication.
14. Willams AC, Barry BW, “ Penetration Enhancer,” Adv. Drug Del. Rev2004 ; 56 : 603-618.
15. Pellet M, Raghavan S.L , Hadgraft J and Davis A.F. “The application of supersaturated systems to percutaneous drug delivery.” In: guy R.H and Dekker , Inc., New York 2003 pp. 305-326.
16. Elsaied EH, Dawaba HM, Ibrahim EA, Afouna MI. Investigation of proniosomes gel as a promising carrier for transdermal delivery of Glimepiride. Universal Journal of Pharmaceutical Research 2016; 1(2): 1-10.
17. Brown MB, Jones SA, Hyaluronic acid : aunique topical vehicle for localized drug delivery of drugs to the skin. JEDV 2000; 19: 308-318.
18. Tsal JC , Guy RH , Thornfeldt CR , Gao WN Feingold KR , Elics PM. “Metabolic approaches to enhances Transdermal Drug Delivery.” Jour pharm. Sci. 1998, 85: 643-648.
19. Berner B. John VA, Pharmacokinetic characterization of Transdermal delivery system. Jour. Clinical Pharmacokinetics 1994; 26(2):121-134.
20. Chauhan N, Kumar K, Pant NC. An updated review on transfersomes: a novel vesicular system for transdermal drug delivery. Universal Journal of Pharmaceutical Research 2017; 2(4): 42-45.
21. Zhou Y, Wu XY. Fine element analysis of diffusional drug release from complexmatrix system, J control Rel 1997; 49: 277-288.
22. Obanewa OA, Oyeniran OT. Development and estimation of anti-inflammatory activity of topical etoricoxib emulgel by carrageenan induced paw oedema method. Universal Journal of Pharmaceutical Research 2019; 4(3): 22-26.
23. Singh J. Tripathi K.T. and Sakia T.R. Effect of penetration enhances on the invitro transport of ephedrine through rate skin and human epidermis from matrix based Transdermal formulations. Drug Dev. Ind. Pharm. 1993; 19: 1623-1628.
24. Wade A. Weller P.J. Handbook of Pharmaceutical Excipients. Washington DC: American Pharmaceutical Publising Association; 1994: 362-366.
25. Francis DJE. Development and evaluation of matrix type transdermal patches of pioglitazone hydrochloride. Universal Journal of Pharmaceutical Research 2016; 1(1): 17-20.
26. Rhaghuram Reddy K, Muttalik S: and Reddy S. Once daily sustained – release matrix tables of nicrorandil: Formulation and Invitro evaluation. AAPS Pharm. Sci. Tech. 2003; 4: 4.
27. Shaila L, Pandey S and Udupo N. Design and evaluation of matrix type membrane controlled. Transdermal drug delivery system of nicotin suitable for use in smoking cessation. Indian Journ. Pharm. Sci. 2006;68 179-184.
28. Umar S, Onyekachi MK. Development and evaluation of transdermal gel of Lornoxicam. Universal Journal of Pharmaceutical Research 2017; 2(1): 15-18.
29. Aarti N, Louk A.R.M.P, Russel.O.P and Richard H.G. Mechanism of oleic acid induced skin permeation enhancement in vivo in humans. Jour. Control. Release 1995; 37: 299-306.
30. Okorochukwu Nnamdi, Ihuaku Emmanuel C. Development and characterization of mucoadhesive patches for buccal delivery of pregabalin. Universal Journal of Pharmaceutical Research 2017; 2(3): 6-9.
2. Chioma ED. Formulation and evaluation of etodolac niosomes by modified ether injection technique. Universal Journal of Pharmaceutical Research 2016; 1(1): 1-4.
3. Chein Y.W.Transdermal drug delivery and delivery system. In, Novel drug delivery system, Vol. 50, Marcel Dekker, Inc., New York, 1992 pp.301-381.
4. Nwobodo NN, Adamude FA, Dingwoke EJ, Ubhenin A. Formulation and evaluation of elastic liposomes of decitabine prepared by rotary evaporation method. Universal Journal of Pharmaceutical Research 2019; 4(3):1-5.
5. Baker W. And Heller J, “Material selection for transdermal delivery system”. In Transdermal drug delivery development issues and research initiatives’, J. Had graft and R.H. guys, Eds, Marcel Dekker, Inc., New York 1989 pp. 293-311.
6. Gurpınar SS, Devrim B, Eryılmaz M. In-vitro antibacterial activity of lactobacilli metabolites loaded hydrogel formulations against pseudomonas aeruginosa. Universal Journal of Pharm Research 2019; 4(4): 9-11.
7. Yamamoto T, Katakabe k, Akiyoshi k, Kank and Asano T. Topical application of glibenclamide lowers blood glucose levels in rats. Diabetes res. clin. PR act 1990:8:19-22.
8. AI-Khamis K. Davis S.S and Had Graft J. Microviscosity and drug release from topical gel formulations Pharm Res.1986; 3: 214-217.
9. Fatima AA, Chukwuka UK. Development and in-vitro evaluation of matrix-type transdermal patches of losartan potassium. Universal Journal of Pharmaceutical Research 2017; 2(2): 16-20.
10. Anon. Transdermal Delivery Systems general drug release standards Pharmacopeia form 1980:14:3860-3865.
11. Brahmankar D.M. Jaiswal.S.B, Biopharmaceutics and Pharmacokinetics A Teatise. Vallabh Prakashan, Delhi 1995, 335-371.
12. Ugochukwu AE, Nnedimkpa OJ, Rita NO. Preparation and characterization of Tolterodine tartrate proniosomes, Universal Journal of Pharmaceutical Research 2017; 2(2): 1-3.
13. Ansel.H.C, Loyd.A.V, Popovich. N.G, Pharmaceutical dosage forms and drug delivery systems. Seventh edition Lippincott Williams and Willkins publication.
14. Willams AC, Barry BW, “ Penetration Enhancer,” Adv. Drug Del. Rev2004 ; 56 : 603-618.
15. Pellet M, Raghavan S.L , Hadgraft J and Davis A.F. “The application of supersaturated systems to percutaneous drug delivery.” In: guy R.H and Dekker , Inc., New York 2003 pp. 305-326.
16. Elsaied EH, Dawaba HM, Ibrahim EA, Afouna MI. Investigation of proniosomes gel as a promising carrier for transdermal delivery of Glimepiride. Universal Journal of Pharmaceutical Research 2016; 1(2): 1-10.
17. Brown MB, Jones SA, Hyaluronic acid : aunique topical vehicle for localized drug delivery of drugs to the skin. JEDV 2000; 19: 308-318.
18. Tsal JC , Guy RH , Thornfeldt CR , Gao WN Feingold KR , Elics PM. “Metabolic approaches to enhances Transdermal Drug Delivery.” Jour pharm. Sci. 1998, 85: 643-648.
19. Berner B. John VA, Pharmacokinetic characterization of Transdermal delivery system. Jour. Clinical Pharmacokinetics 1994; 26(2):121-134.
20. Chauhan N, Kumar K, Pant NC. An updated review on transfersomes: a novel vesicular system for transdermal drug delivery. Universal Journal of Pharmaceutical Research 2017; 2(4): 42-45.
21. Zhou Y, Wu XY. Fine element analysis of diffusional drug release from complexmatrix system, J control Rel 1997; 49: 277-288.
22. Obanewa OA, Oyeniran OT. Development and estimation of anti-inflammatory activity of topical etoricoxib emulgel by carrageenan induced paw oedema method. Universal Journal of Pharmaceutical Research 2019; 4(3): 22-26.
23. Singh J. Tripathi K.T. and Sakia T.R. Effect of penetration enhances on the invitro transport of ephedrine through rate skin and human epidermis from matrix based Transdermal formulations. Drug Dev. Ind. Pharm. 1993; 19: 1623-1628.
24. Wade A. Weller P.J. Handbook of Pharmaceutical Excipients. Washington DC: American Pharmaceutical Publising Association; 1994: 362-366.
25. Francis DJE. Development and evaluation of matrix type transdermal patches of pioglitazone hydrochloride. Universal Journal of Pharmaceutical Research 2016; 1(1): 17-20.
26. Rhaghuram Reddy K, Muttalik S: and Reddy S. Once daily sustained – release matrix tables of nicrorandil: Formulation and Invitro evaluation. AAPS Pharm. Sci. Tech. 2003; 4: 4.
27. Shaila L, Pandey S and Udupo N. Design and evaluation of matrix type membrane controlled. Transdermal drug delivery system of nicotin suitable for use in smoking cessation. Indian Journ. Pharm. Sci. 2006;68 179-184.
28. Umar S, Onyekachi MK. Development and evaluation of transdermal gel of Lornoxicam. Universal Journal of Pharmaceutical Research 2017; 2(1): 15-18.
29. Aarti N, Louk A.R.M.P, Russel.O.P and Richard H.G. Mechanism of oleic acid induced skin permeation enhancement in vivo in humans. Jour. Control. Release 1995; 37: 299-306.
30. Okorochukwu Nnamdi, Ihuaku Emmanuel C. Development and characterization of mucoadhesive patches for buccal delivery of pregabalin. Universal Journal of Pharmaceutical Research 2017; 2(3): 6-9.
Published
13/04/2022
Statistics
337 Views | 206 Downloads
Citatons
How to Cite
[1]
V. Rajput, K. Kumar, I. Ikram, A. K. Sen, and D. Teotia, “Transdermal drug delivery system: a comprehensive review”, Int J Indig Herb Drug, vol. 7, no. 2, pp. 35-39, Apr. 2022.
Issue
Section
Review Articles
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Copyright © Author(s) retain the copyright of this article.
.